prof. dr. P. (Petra) Denig

Professor Drug Utilization Quality

prof. dr. P. (Petra) Denig
E-mail:
p.denig umcg.nl

Research

Research interests

Drug Utilisation Research and Pharmacoepidemiology, diabetes & cardiovascular treatment. Prescribing quality and indicators. Medication adherence. Shared decision making and decision support tools. 

Publications
  1. Correction to: Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study

    SCOPE Work Package 6, de Vries, S. T., van der Sar, M. J. M., Coleman, A. M., Escudero, Y., Rodríguez Pascual, A., Maciá Martínez, M-Á., Cupelli, A., Baldelli, I., Šipić, I., Andrić, A., Michan, L., Denig, P. & Mol, P. G. M., 30-Jun-2020, In : Drug Safety. 3 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia

    Alfian, S. D., Annisa, N., Fajriansyah, F., Perwitasari, D. A., Abdulah, R., Hak, E. & Denig, P., 16-Apr-2020, In : Journal of General Internal Medicine. 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years

    Vos, R. C., den Ouden, H., Daamen, L. A., Bilo, H. J. G., Denig, P. & Rutten, G. E. H. M., 2020, In : BMJ Open Diabetes Research & Care. 8, 1, 7 p., 000949.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands

    de Vries, E., Denig, P., de Vries, S. T., Monster, T. B. M., Hugtenburg, J. G. & Mol, P. G. M., 2020, In : Drug Safety. 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

    de Vries, S. T., Denig, P., Ekhart, C., Mol, P. G. M. & van Puijenbroek, E. P., May-2020, In : Drug Safety. 43, p. 489–495

    Research output: Contribution to journalArticleAcademicpeer-review

View all (171) »

Prizes
  1. Nomination of Top downloaded paper 2018-2019 in BJCP

    Sieta Vries, de (Recipient), Petra Denig (Recipient), Peter Mol (Recipient) & Eugène Puijenbroek, van (Recipient), 30-Apr-2019

    Prize: Other distinctionAcademic

  2. Among the most popular scientific papers in Drug Safety 2018

    Sieta Vries, de (Recipient), Petrus Mol (Recipient) & Petra Denig (Recipient), 2018

    Prize: Other distinctionAcademic

  3. Among the most popular scientific papers in Drug Safety 2019

    Sieta Vries, de (Recipient), Petrus Mol (Recipient) & Petra Denig (Recipient), 2019

    Prize: Other distinctionAcademic

View all (4) »

Activities
  1. Policies on deprescribing – an international view

    Petra Denig (Speaker)
    6-Mar-2020

    Activity: Talk or presentationAcademic

  2. Deprescribing in de praktijk: belemmerende en bevorderende factoren bij artsen en patiënten.

    Petra Denig (Invited speaker)
    1-Apr-2020

    Activity: Talk or presentationProfessional

  3. Assessment of prescribing quality

    Petra Denig (Invited speaker)
    25-Aug-2019

    Activity: Talk or presentationAcademic

View all (55) »

Press / Media
  1. Waarom pillen steeds beter werken [Dagblad van het Noorden]

    Job Boven, van, Jos Kosterink & Petra Denig

    07/03/2020

    1 item of Media coverage

    Press/Media: Expert CommentPopular

  2. Deprescribing: hoe minder, hoe beter

    Petra Denig

    01/11/2019

    1 Media contribution

    Press/Media: Public Engagement ActivitiesProfessional

  3. Verschillen in bijwerkingen bij man en vrouw onder de loep

    Petra Denig

    14/04/2017

    1 item of Media coverage

    Press/Media: ResearchPopular

View all (5) »

ID: 62905